With all due respect, Minister, it seems the need to be flexible applies only to the government, the purchaser. The situation has changed. We started with two doses, and now, a third has just been added; meanwhile, the time frame between the first and second doses is still under review.
How does this change affect the supply of other types of vaccines?
Are you going to prioritize other types of vaccines, instead of pursuing a third dose that is going to cost three times as much?
What do you say to that?